Federal Research Center for Research and Development of Immunobiological Preparations named after V.I. MP Chumakova completed the modernization of equipment. This will increase the production capacity of the KoviVac coronavirus vaccine and make the drug more affordable for Russians, said Center Director Aydar Ishmukhametov. “The modernization of production was successful and completed on schedule. We have already started vaccine production using new equipment. The new equipment will allow the center to increase its capacity by 2–2.5 times. Therefore, we believe that in the near future Kovivak will become much more accessible to all Russian citizens, “the press service of the Ministry of Education and Science of the Russian Federation quoted Mr. Ishmukhametov as quoted by TASS. The director of the Chumakov Center said that only 1 , 5 million doses of KoviVac vaccine. By the end of the year, it is planned to introduce an additional 2.5 million doses of the drug.